HAINES et al v. GlaxoSmithKline LLC
| BENJAMIN HAINES and TIFFANY HAINES |
| GlaxoSmithKline LLC |
| 1:2021cv10272 |
| February 18, 2021 |
| US District Court for the District of Massachusetts |
| F Dennis Saylor |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 24, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 NOTICE re: Status Conference set for 4/21/2021 11:30 AM in Remote Proceeding : Boston before Chief Judge F. Dennis Saylor IV. Counsel of record: To gain access to the hearing please register at the following address: https://https://froms.mad.uscourts.gov/courlist.html. (Counsel shall select "Public" as 'Sign-up Type'. Counsel shall enter Display Name and telephone number, for video access.) This hearing will be conducted by video conference. Counsel of record will receive a video conference invite at the email registered in CM/ECF. If you have technical or compatibility issues with the technology, please notify the session's courtroom deputy as soon as possible.Access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at the following address: #https://https://forms.mad.uscourts.gov/courtlist.html.For questions regarding access to hearings, you may refer to the Court's general orders and public notices available on #www.mad.uscourts.gov or contact media@mad.uscourts.gov.Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violations of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, or denial of entry to future hearings, and such other sanctions, including for contempt of court, as may be deemed appropriate or necessary by the court. Associated Cases: 1:15-md-02657-FDS et al.(McKillop, Matthew) |
| Filing 8 WAIVER OF SERVICE Returned Executed by TIFFANY HAINES, BENJAMIN HAINES. GlaxoSmithKline LLC waiver sent on 2/22/2021, answer due 4/23/2021. (Millrood, Tobias) |
| Filing 7 NOTICE of Appearance by Jennifer M. Stevenson on behalf of GlaxoSmithKline LLC (Stevenson, Jennifer) |
| Filing 6 ELECTRONIC NOTICE of Hearing. Status Conference set for 3/24/2021 at 11:00 AM before Chief Judge F. Dennis Saylor IV. This hearing will be conducted by video conference.If you have technical or compatibility issues with the technology, please notify the session's courtroom deputy as soon as possible.COUNSEL OF RECORD: To gain access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at this link: #https://forms.mad.uscourts.gov/c ourtlist.html For questions regarding access to hearings, you may refer to the Court's general orders and public notices available on #www.mad.uscourts.govor contact media@mad.uscourts.gov.Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violations of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, or denial of entry to future hearings, and such other sanctions, including for contempt of court, as may be deemed appropriate or necessary by the court. Associated Cases: 1:15-md-02657-FDS et al.(Lovett, Jarrett) |
| Filing 5 Electronic Clerk's Notes for proceedings held before Chief Judge F. Dennis Saylor, IV: Status Conference held on 2/24/2021.1) The Court heard updates on the current total of federal and state filings.2) The Court heard updates on discovery. Plaintiffs counsel stated that they were not expecting any further disclosures from Novartis unless it has further communications with the FDA. Novartis informed plaintiffs counsel that it had not heard anything further from the FDA on its proposed labeling changes.3) The Court set a briefing schedule on 2084 GSKs Motion for Summary Judgment Based on Plaintiffs Failure to Provide Admissible Causation Evidence as to Septal Defects and Other Heart Defects. Plaintiffs opposition brief is due on March 5, 2021, and GSKs reply, if any, must be filed by March 12. The Court will hear argument on the motion at the next status conference on March.4) A colloquy was held on 2079 GSKs Motion for Order to Show Cause. The Court took the matter under advisement.5) The Court informed the parties that it would review 45 the Courts order to show cause in Ratliff v. GSK, 20-cv-10047; 31 the Courts order to show cause in Roland v. GSK, 20-cv-10901; and 19 GSKs motion for order to show cause in Nelson v. GSK, 20-cv-11210.6) The Court informed the parties of the difficulties of scheduling a trial date due to the ongoing COVID-19 pandemic. Pending the Courts decision on several motions, the Court tentatively scheduled a trial in the Rodriguez v. GSK, 15-cv-13762 case to begin on October 18, 2021, to last four weeks. Any party who has a potential conflict with the date or length of the trial should notify the Court in writing within 14 days.7) The Court set a status conference for Wednesday, March 24, 2021 at 11:00 a.m. The conference shall be conducted by video conference. The clerk shall post video conference information on the docket via a separate entry. (Court Reporter: Valerie O'Hara at vaohara@gmail.com)(Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al.(Lovett, Jarrett) |
| Filing 4 Summons Issued as to GlaxoSmithKline LLC. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Kelly, Danielle) |
| Filing 3 NOTICE OF MDL CASE OPENED, Direct file in the District of Massachusetts; Haines, et al v. GlaxoSmithKline LLC. In Re: Zofran (Ondansetron) Products Liability Litigation, MDL 2657. (Finn, Mary) |
| Filing 2 ELECTRONIC NOTICE of Case Assignment. Chief Judge F. Dennis Saylor, IV assigned to case. (Finn, Mary) |
| Filing 1 COMPLAINT against GlaxoSmithKline LLC Filing fee: $ 402, receipt number 0101-8641908 (Fee Status: Filing Fee paid), filed by BENJAMIN HAINES, TIFFANY HAINES. (Attachments: #1 Civil Cover Sheet, #2 Case Category Form)(Millrood, Tobias) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
